Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Yersinia pestis | 11 | 2021 | 35 | 3.390 |
Why?
|
| Polyribonucleotide Nucleotidyltransferase | 6 | 2013 | 6 | 2.170 |
Why?
|
| Plague | 8 | 2021 | 25 | 2.060 |
Why?
|
| Yersinia | 4 | 2013 | 4 | 1.530 |
Why?
|
| Anti-Bacterial Agents | 6 | 2024 | 352 | 1.520 |
Why?
|
| Klebsiella pneumoniae | 3 | 2021 | 17 | 1.440 |
Why?
|
| Dust | 3 | 2021 | 54 | 1.390 |
Why?
|
| RNA Helicases | 3 | 2013 | 16 | 1.330 |
Why?
|
| Endoribonucleases | 3 | 2013 | 23 | 1.310 |
Why?
|
| Plague Vaccine | 3 | 2021 | 4 | 1.300 |
Why?
|
| Weightlessness | 3 | 2014 | 16 | 1.300 |
Why?
|
| Multienzyme Complexes | 3 | 2013 | 69 | 1.290 |
Why?
|
| Virulence Factors | 5 | 2013 | 113 | 1.220 |
Why?
|
| Virulence | 15 | 2021 | 223 | 1.210 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 57 | 1.190 |
Why?
|
| Bacterial Proteins | 6 | 2013 | 540 | 1.080 |
Why?
|
| Escherichia coli | 3 | 2018 | 453 | 1.070 |
Why?
|
| Stress, Physiological | 4 | 2014 | 150 | 1.050 |
Why?
|
| Gram-Negative Bacteria | 2 | 2014 | 22 | 0.910 |
Why?
|
| Serratia marcescens | 1 | 2023 | 2 | 0.900 |
Why?
|
| Eukaryota | 1 | 2023 | 20 | 0.880 |
Why?
|
| Biofilms | 4 | 2023 | 168 | 0.850 |
Why?
|
| Klebsiella | 1 | 2021 | 3 | 0.790 |
Why?
|
| Stress, Mechanical | 2 | 2012 | 113 | 0.770 |
Why?
|
| Yersinia pseudotuberculosis | 3 | 2012 | 7 | 0.750 |
Why?
|
| Epithelial Cells | 3 | 2018 | 384 | 0.690 |
Why?
|
| Eukaryotic Cells | 1 | 2018 | 36 | 0.650 |
Why?
|
| Cold Temperature | 3 | 2013 | 40 | 0.620 |
Why?
|
| Bacteria | 3 | 2021 | 255 | 0.620 |
Why?
|
| Enterococcus faecalis | 1 | 2018 | 39 | 0.610 |
Why?
|
| Oxidative Stress | 4 | 2023 | 938 | 0.610 |
Why?
|
| Aeromonas hydrophila | 2 | 2013 | 2 | 0.580 |
Why?
|
| Environmental Exposure | 2 | 2017 | 216 | 0.580 |
Why?
|
| Air Microbiology | 1 | 2015 | 15 | 0.530 |
Why?
|
| Coculture Techniques | 3 | 2023 | 101 | 0.520 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2014 | 22 | 0.520 |
Why?
|
| Gram-Positive Bacteria | 1 | 2014 | 14 | 0.490 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 17 | 0.490 |
Why?
|
| Air Pollutants | 1 | 2015 | 94 | 0.490 |
Why?
|
| Mutation | 4 | 2013 | 1095 | 0.470 |
Why?
|
| Immune Evasion | 1 | 2013 | 16 | 0.470 |
Why?
|
| Animals | 21 | 2024 | 15081 | 0.460 |
Why?
|
| Ofloxacin | 3 | 2012 | 6 | 0.460 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 44 | 0.450 |
Why?
|
| Macromolecular Substances | 1 | 2012 | 96 | 0.420 |
Why?
|
| Protein Subunits | 1 | 2012 | 87 | 0.420 |
Why?
|
| Humans | 21 | 2024 | 37093 | 0.410 |
Why?
|
| Ketolides | 1 | 2011 | 1 | 0.400 |
Why?
|
| Ribonucleases | 1 | 2010 | 30 | 0.380 |
Why?
|
| Bacterial Infections | 1 | 2010 | 43 | 0.370 |
Why?
|
| Space Flight | 1 | 2009 | 11 | 0.350 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2013 | 149 | 0.350 |
Why?
|
| Hela Cells | 4 | 2013 | 366 | 0.340 |
Why?
|
| Macrophages | 6 | 2016 | 439 | 0.320 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2021 | 201 | 0.320 |
Why?
|
| Mice | 13 | 2016 | 5913 | 0.320 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 661 | 0.260 |
Why?
|
| Exoribonucleases | 1 | 2004 | 8 | 0.250 |
Why?
|
| Catalytic Domain | 1 | 2004 | 109 | 0.240 |
Why?
|
| Hydrogen Peroxide | 2 | 2017 | 190 | 0.240 |
Why?
|
| China | 2 | 2021 | 196 | 0.230 |
Why?
|
| Cross Infection | 1 | 2024 | 38 | 0.230 |
Why?
|
| Antibodies, Bacterial | 2 | 2021 | 109 | 0.220 |
Why?
|
| Manganese | 1 | 2023 | 87 | 0.200 |
Why?
|
| Zinc | 1 | 2023 | 128 | 0.200 |
Why?
|
| Lead | 1 | 2023 | 93 | 0.200 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2012 | 52 | 0.200 |
Why?
|
| Weightlessness Simulation | 2 | 2012 | 21 | 0.200 |
Why?
|
| Vaccines, Attenuated | 1 | 2021 | 72 | 0.190 |
Why?
|
| Metals, Heavy | 1 | 2021 | 60 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1198 | 0.170 |
Why?
|
| Disease Models, Animal | 6 | 2016 | 1371 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 515 | 0.160 |
Why?
|
| HT29 Cells | 1 | 2017 | 45 | 0.150 |
Why?
|
| Environmental Microbiology | 1 | 2017 | 26 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 61 | 0.140 |
Why?
|
| Trifluoperazine | 1 | 2016 | 5 | 0.140 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2016 | 7 | 0.140 |
Why?
|
| Salmonella Infections | 1 | 2016 | 17 | 0.140 |
Why?
|
| Pregnenediones | 1 | 2016 | 5 | 0.140 |
Why?
|
| Commiphora | 1 | 2016 | 5 | 0.140 |
Why?
|
| Lung | 1 | 2018 | 446 | 0.130 |
Why?
|
| RNA, Small Nucleolar | 1 | 2015 | 2 | 0.130 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 2015 | 3 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.130 |
Why?
|
| Particulate Matter | 1 | 2015 | 51 | 0.130 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 41 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 29 | 0.130 |
Why?
|
| Cell Line | 1 | 2018 | 1354 | 0.120 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 52 | 0.120 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 82 | 0.120 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 118 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 252 | 0.120 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2013 | 5 | 0.120 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 78 | 0.120 |
Why?
|
| Rotation | 1 | 2013 | 24 | 0.120 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 26 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2012 | 19 | 0.110 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 33 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2013 | 132 | 0.110 |
Why?
|
| Lipoproteins | 1 | 2012 | 64 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2012 | 30 | 0.110 |
Why?
|
| Female | 7 | 2016 | 20969 | 0.100 |
Why?
|
| Peptides | 1 | 2015 | 320 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 186 | 0.100 |
Why?
|
| Bioterrorism | 1 | 2011 | 20 | 0.100 |
Why?
|
| Guinea Pigs | 1 | 2011 | 145 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 220 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 689 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2009 | 206 | 0.090 |
Why?
|
| Rats | 3 | 2012 | 3483 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 803 | 0.080 |
Why?
|
| Yersinia Infections | 1 | 2007 | 2 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 90 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1518 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2011 | 400 | 0.070 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2006 | 3 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1609 | 0.070 |
Why?
|
| Protein Transport | 1 | 2007 | 302 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 73 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 1103 | 0.070 |
Why?
|
| Quorum Sensing | 1 | 2024 | 13 | 0.060 |
Why?
|
| Agriculture | 1 | 2024 | 56 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2024 | 77 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2013 | 166 | 0.050 |
Why?
|
| AIDS Vaccines | 1 | 2002 | 30 | 0.050 |
Why?
|
| Cities | 1 | 2021 | 63 | 0.050 |
Why?
|
| Texas | 1 | 2021 | 324 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 192 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2021 | 753 | 0.040 |
Why?
|
| Amoxapine | 1 | 2016 | 1 | 0.040 |
Why?
|
| Doxapram | 1 | 2016 | 1 | 0.040 |
Why?
|
| Resins, Plant | 1 | 2016 | 3 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 40 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2016 | 30 | 0.030 |
Why?
|
| Plant Gums | 1 | 2016 | 7 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 143 | 0.030 |
Why?
|
| HIV-1 | 1 | 2002 | 706 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 45 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 65 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 325 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 50 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 127 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 259 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 492 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 59 | 0.030 |
Why?
|
| Animal Structures | 1 | 2013 | 14 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2012 | 5 | 0.030 |
Why?
|
| Gentamicins | 1 | 2012 | 10 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 40 | 0.030 |
Why?
|
| Immune Sera | 1 | 2012 | 59 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2012 | 2 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 864 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2012 | 72 | 0.030 |
Why?
|
| Luciferases | 1 | 2012 | 63 | 0.030 |
Why?
|
| Immunization | 1 | 2012 | 92 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2012 | 136 | 0.030 |
Why?
|
| Locomotion | 1 | 2013 | 97 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 186 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 972 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2012 | 399 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 474 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1568 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2231 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1398 | 0.020 |
Why?
|
| HIV Infections | 1 | 2002 | 2303 | 0.020 |
Why?
|
| Phagocytes | 1 | 2006 | 6 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2006 | 30 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 66 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2006 | 110 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 208 | 0.020 |
Why?
|
| Retroviridae Infections | 1 | 2002 | 3 | 0.010 |
Why?
|
| Vaccines, DNA | 1 | 2002 | 23 | 0.010 |
Why?
|
| Vaccines, Subunit | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cats | 1 | 2002 | 69 | 0.010 |
Why?
|
| Primates | 1 | 2002 | 36 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1742 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2002 | 64 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 204 | 0.010 |
Why?
|